Medlab Clinical Limited reported earnings results for the half year ended December 31, 2022. For the half year, the company reported sales was AUD 0.561015 million compared to AUD 0.434889 million a year ago. Revenue was AUD 2.42 million compared to AUD 3.04 million a year ago.

Net loss was AUD 4.82 million compared to AUD 3.05 million a year ago. Basic loss per share was AUD 2.1091 compared to AUD 1.3392 a year ago. Diluted loss per share was AUD 2.1091 compared to AUD 1.3392 a year ago.